US 11,807,609 B2
Deuterated compounds as immunomodulators
Pingchen Fan, Fremont, CA (US); Rebecca M. Lui, Mountain View, CA (US); Venkat Reddy Mali, Cupertino, CA (US); Rajinder Singh, Belmont, CA (US); Yibin Zeng, Foster City, CA (US); and Penglie Zhang, Foster City, CA (US)
Assigned to CHEMOCENTRYX, INC., Thousand Oaks, CA (US)
Filed by CHEMOCENTRYX, INC., Mountain View, CA (US)
Filed on Oct. 9, 2020, as Appl. No. 17/066,986.
Application 17/066,986 is a continuation of application No. 16/173,914, filed on Oct. 29, 2018, abandoned.
Claims priority of provisional application 62/578,586, filed on Oct. 30, 2017.
Prior Publication US 2021/0276955 A1, Sep. 9, 2021
Int. Cl. C07D 211/60 (2006.01); A61K 45/06 (2006.01); A61K 31/451 (2006.01)
CPC C07D 211/60 (2013.01) [A61K 31/451 (2013.01); A61K 45/06 (2013.01); C07B 2200/05 (2013.01)] 2 Claims
 
1. A compound or a pharmaceutically acceptable salt thereof, selected from the group consisting of

OG Complex Work Unit Chemistry